Insiders · Profile

Freitag Gregory Gene

Director at PDS Biotechnology · Director at Axogen. Filing since 21 Nov 2011. CIK 0001492710

Company
Date
Role
Action
Shares
Amount
Of holding
28 Feb 2025
Director
Bought
15,060
$25.00K
32.6%
7 Mar 2024
Director
Sold at will
25,000
$225.00K
8.4%
1 Jun 2023
Director
Sold at will
41,980
$365.78K
12.6%
23 May 2023
Director
Sold at will
7,468
$68.90K
2.2%
14 Nov 2022
Director
Sold, plan not stated
13,000
$165.62K
3.7%
8 Nov 2022
Director
Sold, plan not stated
13,000
$162.50K
3.6%
10 Aug 2022
Director
Sold, plan not stated
8,886
$86.16K
2.4%
8 Aug 2022
Director
Sold, plan not stated
13,046
$135.29K
3.4%
4 Aug 2022
Director
Sold, plan not stated
24,000
$255.36K
5.8%
15 Jun 2021
Director
Bought
5,882
$50.00K
14.6%
25 Feb 2021
Director
Sold, plan not stated
24,000
$529.44K
9.5%
29 Dec 2020
Director
Sold, plan not stated
916
$16.31K
0.4%
21 Dec 2020
Director
Sold, plan not stated
379
$6.22K
0.2%
30 Nov 2018
General Counsel
Sold, plan not stated
45,000
$1.49M
31.9%
15 Nov 2018
General Counsel
Sold, plan not stated
20,000
$645.00K
12.4%
3 Jun 2014
CFO
Bought
200
$468.00
0.7%
2 Jun 2014
CFO
Bought
5,000
$12.25K
20.6%
14 Aug 2013
CFO
Bought
8,334
$25.00K
34.3%
30 Dec 2011
CFO
Bought
9,318
$22.36K
62.1%
22 Nov 2011
CFO
Bought
9,000
$26.25K
150%
21 Nov 2011
CFO
Bought
6,000
$17.40K
opened
21 decisions on file.